SLC25A13 and hepatocellular carcinoma: In HCC, the downregulation of NAT8L mediates the efflux of aspartate from mitochondria through the transporter protein SLC25A13, thereby activating the PPP, promoting purine biosynthesis, and contributing to HCC proliferation (121).